These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10219746)

  • 21. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
    Williams CL; Hay JE; Huiatt TW; Lennon VA
    Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunology of paraneoplastic syndromes: overview.
    Posner JB
    Ann N Y Acad Sci; 2003 Sep; 998():178-86. PubMed ID: 14592873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibody activity in Lambert-Eaton myasthenic syndrome.
    Lancet; 1988 Apr; 1(8591):920. PubMed ID: 2451774
    [No Abstract]   [Full Text] [Related]  

  • 24. Thymus, thymoma and myasthenia gravis.
    Fujii Y
    Surg Today; 2013 May; 43(5):461-6. PubMed ID: 22948665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis.
    Cuénoud S; Feltkamp TE; Fulpius BW; Oosterhuis HJ
    Neurology; 1980 Feb; 30(2):201-2. PubMed ID: 7188802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgG subclass distribution of myasthenia gravis thymoma-associated antiskeletal muscle antibodies.
    Smith CI; Aarli JA; Hammarström L; Persson MA
    Neurology; 1984 Aug; 34(8):1094-6. PubMed ID: 6540388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralizing antibodies against endogenous interferon in myasthenia gravis patients.
    Bagnato F; Clemenzi A; Scagnolari C; Strizzi L; Di Pasquale A; Bellomi F; Di Marco P; Antonelli G; Antonini G
    Eur Cytokine Netw; 2004; 15(1):24-9. PubMed ID: 15217749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymoma-specific antibodies in sera from patients with myasthenia gravis demonstrated by indirect haemagglutination.
    Aarli JA; Lefvert AK; Tönder O
    J Neuroimmunol; 1981 Dec; 1(4):421-7. PubMed ID: 7346525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraneoplastic diseases associated with thymoma.
    Evoli A; Minicuci GM; Vitaliani R; Battaglia A; Della Marca G; Lauriola L; Fattorossi A
    J Neurol; 2007 Jun; 254(6):756-62. PubMed ID: 17325820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal deterioration of neurological symptoms and increase of serum acetylcholine receptor antibody levels after thymectomy: a case report of a cat with myasthenia gravis.
    Nagata N; Miyoshi T; Otake Y; Suzuki H; Kagawa Y; Yamagami T; Irie M
    J Vet Med Sci; 2017 Jan; 78(12):1893-1896. PubMed ID: 27593682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The clinico-immunological characteristics of myasthenia patients].
    Shevniuk MM; Shumilina ES; Dubov AM
    Lik Sprava; 1996; (7-9):81-3. PubMed ID: 9072276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability.
    Ansevin CF
    Neurology; 2000 Aug; 55(3):458-9. PubMed ID: 10932298
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunoglobulin allotypes in myasthenia gravis patients with a thymoma.
    Gilhus NE; Pandey JP; Gaarder PI; Aarli JA
    J Autoimmun; 1990 Jun; 3(3):299-305. PubMed ID: 2397020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
    Mygland A; Aarli JA; Matre R; Gilhus NE
    J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myasthenia gravis and autoimmunity.
    Whitaker JN
    Adv Intern Med; 1980; 26():489-510. PubMed ID: 6164271
    [No Abstract]   [Full Text] [Related]  

  • 36. Acquired generalised neuromyotonia, cutaneous lupus erythematosus and alopecia areata in a patient with myasthenia gravis.
    O'Sullivan SS; Mullins GM; Neligan A; McNamara B; Galvin RJ
    Clin Neurol Neurosurg; 2007 May; 109(4):374-5. PubMed ID: 17239529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decline of disease activity and autoantibodies to desmoglein 3 and envoplakin by oral prednisolone in paraneoplastic pemphigus with benign thymoma.
    Ishii N; Hamada T; Koga H; Sogame R; Ohyama B; Fukuda S; Natsuaki Y; Dainichi T; Karashima T; Nakama T; Tsuruta D; Hashimoto T
    Eur J Dermatol; 2012; 22(4):547-9. PubMed ID: 22548836
    [No Abstract]   [Full Text] [Related]  

  • 38. Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like disease.
    Wadhera A; Maverakis E; Mitsiades N; Lara PN; Fung MA; Lynch PJ
    J Am Acad Dermatol; 2007 Oct; 57(4):683-9. PubMed ID: 17433850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Striational autoantibodies in myasthenia gravis patients recognize I-band titin epitopes.
    Lübke E; Freiburg A; Skeie GO; Kolmerer B; Labeit S; Aarli JA; Gilhus NE; Wollmann R; Wussling M; Rüegg JC; Linke WA
    J Neuroimmunol; 1998 Jan; 81(1-2):98-108. PubMed ID: 9521611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spontaneous neutralising antibodies to interferon--alpha and interleukin-12 in thymoma-associated autoimmune disease.
    Meager A; Vincent A; Newsom-Davis J; Willcox N
    Lancet; 1997 Nov; 350(9091):1596-7. PubMed ID: 9393342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.